Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2016-01-21 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA FRETTE (38260), Isere
PHARMACIE DE LA FRETTE : revenue, balance sheet and financial ratios
PHARMACIE DE LA FRETTE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA FRETTE (38260),
this company of category PME
shows in 2023 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA FRETTE (SIREN 817924632)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 247 980 €
2 231 367 €
1 963 737 €
1 728 313 €
1 664 887 €
1 724 038 €
1 770 248 €
1 079 506 €
Net income
50 839 €
59 159 €
-14 867 €
27 588 €
101 800 €
64 606 €
75 864 €
122 259 €
100 529 €
32 411 €
EBITDA
N/C
N/C
3 792 €
69 641 €
141 719 €
96 531 €
116 631 €
182 886 €
161 979 €
56 493 €
Net margin
N/C
N/C
-0.7%
1.2%
5.2%
3.7%
4.6%
7.1%
5.7%
3.0%
Revenue and income statement
In 2025, PHARMACIE DE LA FRETTE generates positive net income of 51 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 32 k€ -> 51 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
50 839 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 162%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
161.568%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
32.32%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA FRETTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
3106.81
853.219
422.265
311.698
235.551
166.919
212.512
253.031
199.098
161.568
Financial autonomy
2.529
9.016
16.726
21.992
25.768
32.547
28.29
24.777
28.673
32.32
Repayment capacity
43.531
12.644
9.686
13.723
16.533
4.999
64.647
-533.111
None
None
Cash flow / Revenue
2.804%
5.449%
6.706%
4.455%
3.344%
4.594%
0.788%
-0.109%
None%
None%
Sector positioning
Debt ratio
161.572025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of PHARMACIE DE LA FRETTE (161.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
32.32%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE DE LA FRETTE (32.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
-533.11 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DE LA FRETTE (-533.11) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 97.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
97.879
Liquidity indicators evolution PHARMACIE DE LA FRETTE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
119.369
128.056
142.605
128.043
126.095
42.566
161.231
141.876
114.697
97.879
Interest coverage
32.537
16.928
12.476
17.612
20.789
13.29
60.034
126.688
None
None
Sector positioning
Liquidity ratio
97.882025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-9 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA FRETTE (97.88) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
126.69x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE DE LA FRETTE (126.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA FRETTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
141 178 €
160 030 €
207 522 €
207 745 €
201 020 €
181 744 €
254 443 €
238 668 €
0 €
0 €
Inventory turnover (days)
50
41
44
39
41
35
28
33
0
0
Customer payment term (days)
9
3
5
5
0
6
5
5
0
0
Supplier payment term (days)
89
37
44
29
45
33
31
41
0
0
Positioning of PHARMACIE DE LA FRETTE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA FRETTE is estimated at
807 583 €
(range 548 030€ - 1 267 209€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
548k€807k€1267k€
807 583 €Range: 548 030€ - 1 267 209€
NAF 5 année 2025
Valuation method used
Net Income Multiple
50 839 €
×
15.9x
=807 584 €
Range: 548 030€ - 1 267 210€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA FRETTE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA FRETTE
What is the revenue of PHARMACIE DE LA FRETTE ?
The revenue of PHARMACIE DE LA FRETTE in 2023 is 2.2 M€.
Is PHARMACIE DE LA FRETTE profitable?
Yes, PHARMACIE DE LA FRETTE generated a net profit of 51 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA FRETTE ?
The headquarters of PHARMACIE DE LA FRETTE is located in LA FRETTE (38260), in the department Isere.
Where to find the tax return of PHARMACIE DE LA FRETTE ?
The tax return of PHARMACIE DE LA FRETTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA FRETTE operate?
PHARMACIE DE LA FRETTE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart